Choice of the Surgical Access for Malignant Tumors of the Central Zone of the Facial Skeleton
##article.numberofdownloads## 14
##article.numberofdownloads## 2
##article.numberofviews## 49
pdf (Русский)
pdf

Keywords

sinonasal tumour
surgery
endoscopic approach
dismasking
bicoronal access

How to Cite

Petrova, A. A., Sukorceva, N. S., Shevalgin , A. A., Nebezhev, A. A., & Reshetov, I. V. (2025). Choice of the Surgical Access for Malignant Tumors of the Central Zone of the Facial Skeleton. Voprosy Onkologii, 71(2), OF–2118. https://doi.org/10.37469/0507-3758-2025-71-2-OF-2118

Abstract

This review describes the issue of surgical treatment for tumors in the middle third of the facial skeleton. Given the anatomical characteristics, clinical manifestations and social significance of this area, the operation should be as radical as possible, with minimal aesthetic and functional impairment in the postoperative period, in order to improve the oncological outcome and preserve the patient's quality of life. Surgical treatment is considered the "gold standard" for the treatment of sinonasal tumors, but the introduction of new methods of local control, such as intra-arterial chemoembolization, intra-operative radiation therapy and alternative radiation therapy sources and modalities, are more evidence and are helping surgeons to reduce the morbidity of surgical treatment while maintaining its radicality. The standard traumatic approaches through the medial line of the face are still used. While endoscopic access has its advantages and limitations, it is gaining popularity for the treatment of sinonasal tumors. If the primary tumor is spread over two or more anatomical compartments, endoscopic access is not applicable. Therefore, the "dismasking" bicoronal approach can be used to reduce morbidity in the visible facial area. The "dismasking" bicoronal access provides a large surgical field, helps to adequately assess the extent of the tumor and radically removes it with surrounding healthy tissue, while preserving the integrity of the facial skin, muscles and function of the facial and other cranial nerves and critical structures. To achieve better treatment results "dismasking" bicoronal access should be considered as an alternative to standard transfacial access and endoscopic method, taking into account the indications and limitations for each patient individually.

https://doi.org/10.37469/0507-3758-2025-71-2-OF-2118
##article.numberofdownloads## 14
##article.numberofdownloads## 2
##article.numberofviews## 49
pdf (Русский)
pdf

References

Каприн А.Д., Старинский В.В., Шахзадова А.О. Состояние онкологической помощи населению России в 2021 г. МНИОИ им. П.А. Герцена — филиал ФГБУ «НМИЦ радиологии» Минздрава России. 2022: илл.; 239.-URL: https://oncology-association.ru/wp-content/uploads/2022/05/sostoyanie-onkologicheskoj-pomoshhi-naseleniyu-rossii-v-2021-godu.pdf?ysclid=m334t3k2o1814738027 . [Kaprin A.D., Starinskij V.V., Shahzadova A.O. Sostoyanie onkologicheskoj pomoshchi naseleniyu Rossii v 2021 godu. Moscow: P.A. Herzen MNIOI — a branch of FGBU “NMRC Radiology” of the Ministry of Health of Russia. 2021: 239(ill.).-URL: https://oncology-association.ru/wp-content/uploads/2022/05/sostoyanie-onkologicheskoj-pomoshhi-naseleniyu-rossii-v-2021-godu.pdf?ysclid=m334t3k2o1814738027.]

Thawani R., Kim M.S., Arastu A., et al. The contemporary management of cancers of the sinonasal tract in adults. CA Cancer J Clin. 2023; 73: 72-112.-DOI: doi.org/10.3322/caac.21752.

Taylor M.A., Saba N.F. Cancer of the paranasal sinuses. Hematol Oncol Clin North Am. 2021; 35: 949-62.-DOI: 10.1016/j.hoc.2021.05.006.

Turri-Zanoni M., Gravante G., Castelnuovo P. Molecular biomarkers in sinonasal cancers: new frontiers in diagnosis and treatment. Curr Oncol Rep. 2022; 24: 55-67.-DOI: 10.1007/s11912-021-01154-3.

Sakata K., Maeda A., Rikimaru H., et al. Advantage of extended craniofacial resection for advanced malignant tumors of the nasal cavity and paranasal sinuses: long-term outcome and surgical management. World Neurosurg. 2016; 89: 240-54.-DOI: 10.1016/j.wneu.2016.02.019.

Ackall F.Y., Issa K., Barak I., et al. Survival outcomes in sinonasal poorly differentiated squamous cell carcinoma. Laryngoscope. 2021; 131: E1040-8.-DOI: 10.1002/lary.29090.

Lõpez F., Rodrigo J.P., Cardesa A., et al. Update on primary head and neck mucosal melanoma. Head Neck. 2016; 38: 147-55.-DOI: 10.1002/hed.23872.

Abt N.B., Miller L.E., Mokhtari T.E., et al. Nasal and paranasal sinus mucosal melanoma: Long-term survival outcomes and prognostic factors. Am J Otolaryngol — Head Neck Med Surg. 2021; 42.-DOI: 10.1016/j.amjoto.2021.103070.

Limaiem F., Das J.M. Esthesioneuroblastoma. StatPearls. Treasure Island (FL): StatPearls Publishing. 2023.

Haerle S.K., Gullane P.J., Witterick I.J., et al. Sinonasal carcinomas. epidemiology, pathology, and management. Neurosurg Clin N Am. 2013; 24: 39-49.-DOI: 10.1016/j.nec.2012.08.004.

Caudell J.J., Gillison M.L., Maghami E., et al. NCCN Guidelines® Insights: head and neck cancers, version 1.2022. JNCCN. 2022; 20: 224-34.-DOI: 10.6004/jnccn.2022.0016.

Jafari A., Shen S.A., Qualliotine J.R., et al. Impact of margin status on survival after surgery for sinonasal squamous cell carcinoma. Int Forum Allergy Rhinol. 2019; 9: 1205-11.-DOI: 10.1002/alr.22415.

Hermsen M.A., Bossi P., Franchi A., Lechner M. Sinonasal cancer: improving classification, stratification and therapeutic options. Cancers (Basel). 2023; 15.-DOI: 10.3390/cancers15061675.

Ketcham A.S., Wilkins R.H., Van Buren J.M., Smith R.R. A combined intracranial facial approach to the paranasal sinuses. Am J Surg. 1963; 106: 698-703.-DOI: 10.1016/0002-9610(63)90387-8.

López F., Shah J.P., Beitler J.J., et al. The selective role of open and endoscopic approaches for sinonasal malignant tumours. Adv Ther. 2022; 39: 2379-97.-DOI: 10.1007/s12325-022-02080-x.

Polyakov A.P., Reshetov I. V., Zaytsev A.M., et al. A surgical approach as dysmasking in patients with malignant tumors of the paranasal sinuses and skull base. Head and Neck Tumors (HNT). 2015; 5: 16.-DOI: 10.17650/2222-1468-2015-5-3-16-23.

Albonette-Felicio T., Rangel G.G., Martinéz-Pérez R., et al. Surgical management of anterior skull-base malignancies (endoscopic vs. craniofacial resection). J Neurooncol. 2020; 150: 429-36.-DOI: 10.1007/s11060-020-03413-y.

Liu Q., Huang X., Chen X., et al. Long-term outcomes of endoscopic resection versus open surgery for locally advanced sinonasal malignancies in combination with radiotherapy. J Neurol Surg B Skull Base. 2022; 85: 28-37.-DOI: 10.1055/a-1980-8567.

Povolotskiy R., Farber N.I., Bavier R.D., et al. Endoscopic versus open resection of non‐squamous cell carcinoma sinonasal malignancies. Laryngoscope. 2020; 130: 1872-6.-DOI: 10.1002/lary.28270.

Barinsky G.L., Azmy M.C., Kilic S., et al. Comparison of open and endoscopic approaches in the resection of esthesioneuroblastoma. Annals of Otology, Rhinology & Laryngology. 2021; 130: 136-41.-DOI: 10.1177/0003489420939582.

Kashiwazaki R., Turner M.T., Geltzeiler M., et al. The endoscopic endonasal approach for sinonasal and nasopharyngeal adenoid cystic carcinoma. Laryngoscope. 2020; 130: 1414-21. -DOI: 10.1002/lary.28100.

Farber N.I., Bavier R.D., Crippen M.M., et al. Comparing endoscopic resection and open resection for management of sinonasal mucosal melanoma. Int Forum Allergy Rhinol. 2019; 9: 1492-8.-DOI: 10.1002/alr.22422.

Jiang S., Fan R., Zhang H., et al. Outcomes of endoscopic and open resection of sinonasal malignancies: a systematic review and meta-analysis. Braz J Otorhinolaryngol. 2022; 88: 19-31.-DOI: 10.1016/j.bjorl.2021.06.004.

Husain Q., Joshi R.R., Cracchiolo J.R., et al. Surgical management patterns of sinonasal malignancy: a population-based study. J Neurol Surg B Skull Base. 2019; 80: 371-9.-DOI: 10.1055/S-0038-1675233.

Jiang S., Fan R., Zhang H., et al. Outcomes of endoscopic and open resection of sinonasal malignancies: a systematic review and meta-analysis. Braz J Otorhinolaryngol. 2022; 88: 19-31.-DOI: 10.1016/j.bjorl.2021.06.004.

Lu V.M., Ravindran K., Phan K., et al. Surgical outcomes of endoscopic versus open resection for primary sinonasal malignancy: a meta-analysis. Am J Rhinol Allergy. 2019; 33: 608-16.-DOI: 10.1177/1945892419856976.

Har-El G. Anterior craniofacial resection without facial skin incisions — A review. Otolaryngology — Head and Neck Surgery. 2004; 130: 780-7.-DOI: 10.1016/j.otohns.2004.01.015.

Jaju H. Unfavourable results in skull base surgery. Indian Journal of Plastic Surgery. 2013; 46: 239-46.-DOI: 10.4103/0970-0358.118599.

Hartley F., Kenyon Jh. Experiences in cerebral surgery. Ann Surg. 1907; 45: 481-530.-DOI: 10.1097/00000658-190704000-00001.

Tessier P. The definitive plastic surgical treatment of the severe facial deformities of craniofacial dysostosis. Plast Reconstr Surg. 1971; 48: 419-42.-DOI: 10.1097/00006534-197111000-00002.

Tajima S., Tanaka Y., Imai K., et al. Extended coronal flap — “dismasking flap” for craniofacial and skull base surgery. Bull Osaka Med Sch. 1993; 39: 1-8.

Frodel J.L., Marentette L.J. The coronal approach: anatomic and technical considerations and morbidity. Archives of Otolaryngology — Head and Neck Surgery. 1993; 119: 201-7.-DOI: 10.1001/archotol.1993.01880140091014.

Sykes J.M., Riedler K.L., Cotofana S., Palhazi P. Superficial and deep facial anatomy and its implications for rhytidectomy. Facial Plast Surg Clin North Am. 2020; 28: 243-51.-DOI: 10.1016/j.fsc.2020.03.005.

Higashino T., Okazaki M., Mori H., et al. Microanatomy of sensory nerves in the upper eyelid: A cadaveric anatomical study. Plast Reconstr Surg. 2018; 142: 345-53.-DOI: 10.1097/PRS.0000000000004554.

Hwang K. Surgical anatomy of the facial nerve relating to facial rejuvenation surgery. Journal of Craniofacial Surgery. 2014; 25: 1476-81.-DOI: 10.1097/SCS.0000000000000577.

Koda H., Tsunoda A., Iida H., et al. Facial dismasking flap for removal of tumors in the craniofacial region. Laryngoscope. 2007; 117: 1533-8.-DOI: 10.1097/MLG.0b013e31806dd040.

Kishimoto S., Tsunoda A., Koda H. 2010 Nasal downward swing approach coupled with the facial dismasking flap. Auris Nasus Larynx. 2010; 37: 217-9.-DOI: 10.1016/j.anl.2009.07.005.

Masuda M., Fukushima J., Fujimura A., Uryu H. Combined transcervical and orbitozygomatic approach for the removal of a nasopharyngeal adenocarcinoma. Auris Nasus Larynx. 2016; 43: 192-6.-DOI: 10.1016/j.anl.2015.06.006.

Ishii Y., Yano T., Ito O. Use of the facial dismasking flap approach for surgical treatment of a multifocal craniofacial abscess. Arch Plast Surg. 2018; 45: 271-4.-DOI: 10.5999/aps.2017.00969.

Ohno K., Tsunoda A., Shirakura S., et al. The approaches and outcomes of skull base surgery for pediatric sarcoma after initial therapy. Auris Nasus Larynx. 2011; 38: 208-14.-DOI: 10.1016/j.anl.2010.08.005.

Fujimoto T., Imai K., Takahashi M., et al. Retrospective assessment of the dismasking flap procedure as a craniofacial approach. J Neurosurg Pediatr. 2011; 7: 345-50.-DOI: 10.3171/2011.1.PEDS10271.

Kyrgias G., Hajiioannou J., Tolia M., et al. Intraoperative radiation therapy (IORT) in head and neck cancer: A systematic review. Medicine (US). 2016; 95: e5035.-DOI: 10.1097/MD.0000000000005035.

Chiodo C., Gros S., Emami B., et al. Intraoperative radiation therapy for locally advanced and recurrent head and neck cancer. Mol Clin Oncol. 2022; 17.-DOI: 10.3892/mco.2022.2591.

Sarria G.R., Petrova V., Wenz F., et al. Intraoperative radiotherapy with low energy x-rays for primary and recurrent soft-tissue sarcomas. Radiation Oncology. 2020;15.-DOI: 10.1186/s13014-020-01559-7.

Villafuerte C.V.L., Ylanan A.M.D., Wong H.V.T., et al. Systematic review of intraoperative radiation therapy for head and neck cancer. Ecancermedicalscience. 2022; 16.-DOI: 10.3332/ecancer.2022.1488.

Homma A., Mikami M., Matsuura K., et al. Dose-finding and efficacy confirmation trial of the superselective intra-arterial infusion of cisplatin and concomitant radiation therapy for locally advanced maxillary sinus cancer (JCOG1212): Results of the efficacy confirmation phase in patients with T4aN0M0. International Journal of Radiation Oncology*Biology*Physics. 2024; 118: 1271-81.-DOI: 1016/j.ijrobp.2023.11.031.

Ikeda M., Suzuki M., Matsuzuka T., et al. Neoadjuvant superselective intra-arterial cisplatin chemoradiotherapy combined with surgery in patients with T4 squamous cell carcinoma of the maxillary sinus. Journal of Oral and Maxillofacial Surgery. 2022; 80: 1445-50.-DOI: 10.1016/j.joms.2022.04.014.

Tsushima N., Kano S., Suzuki T., et al. Title: Salvage surgery improves the treatment outcome of patients with residual/recurrent maxillary sinus cancer after superselective intra-arterial cisplatin infusion with concomitant radiation therapy. n.d.

Yano T., Okazaki M., Tanaka K., et al. Indication for and limitation of the facial dismasking flap approach for skull base surgery to achieve the best esthetical and functional results. Ann Plast Surg. 2017; 78: 49-53.-DOI: 10.1097/SAP.0000000000000662.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

© АННМО «Вопросы онкологии», Copyright (c) 2025